Summary
32 / 100 · Bulios Score
What speaks for it
- It has no debt and holds $34.4M in cash.
What to watch
- Revenue fell by 38% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It cut its dividend by 89% last year.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
Revenue fell by 14% a year over 5 years. Over the last 3 years it fell by 38% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $30.6M.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 2.50%
You receive $0.14 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 2
- Sell 0
No analyst has published a price target.
50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Chemicals 62%
- Biofuels 38%
By region
- UNITED STATES 99%
- Non-US 1.0%
Chemicals brings in 62% of revenue.
Segments in detail